About Arkin
Arkin is a private equity firm founded in 2009. It is primarily based in Herzliya, Israel. In the last 12 months, it has participated in 10 funding rounds.
Overall Arkin portfolio has seen 5 unicorns, 10 IPOs and 9 acquisitions including key companies like LinkedIn, Via and Biogen. A lot of funds co-invest with Arkin, with names like Sixty Degree Capital sharing a substantial percentage of its portfolio.
Arkin has a team of 19 people, including 7 partners.
Arkin's Portfolio
They have invested in a total of 68 companies. Their most recent investment was in Hemispheric AI (Series C round) on Jul 15, 2026. Here is the most recent investment by Arkin:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jul 15, 2026 | Series C | 5288 | ||
Jun 22, 2026 | Series A | 5198 | ||
Jun 03, 2026 | Seed | 8471 | ||
Apr 07, 2026 | Post IPO | 1770 |
Here is the portfolio snapshot of Arkin:
Investments by Year
The maximum number of investments were made in 2025
Team profile of Arkin
Arkin has a team of 19 members including 7 Partners and 9 Principals located in Israel and United States. Arkin's team does not sit on the board of any company as of now.Here is a list of top team members in Arkin:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | New York City | - | ||
Partner | Israel | - | ||
Partner | - | - | ||
Partner | Tel Mond | - | ||
Partner | Tel Aviv Yafo | - | ||
Partner | Israel | - | ||
Principal | Tel Aviv | - | ||
Principal | Pasadena | - | ||
Principal | Israel | - | ||
Principal | Israel | - |
Co-investors of Arkin
Over the past 17 years, 50 investors have co-invested in Arkin's portfolio companies.
- Top Co-investors of Arkin: 50 investors entered a company along with Arkin. These include investors like Sixty Degree Capital (2 companies).
Arkin News
•
•
Bionyra Pharma Secures €143 Million Series A Funding for Biologic MedicinesStartup Rise EU•Jun 23, 2026•Jeito, Sofinnova Partners, Sixty Degree Capital, Vives Fund and 3 others
•
Sofinnova, Sanofi alum unveil Bionyra with $165M and next-gen immunology assetsBioSpace•Jun 22, 2026•Sofinnova Partners, Jeito, Sixty Degree Capital, Vives Fund and 3 others
•
Shifters Raises $10.2 Million Seed Funding Led by Ace Capital PartnersMassinvestor•Jun 03, 2026•Ace Capital Partners, Aurelius Capital Management, Arkin, World Fund and 1 other
•
•
Briggs Morrison's Crossbow Unveils $77M Series B for T Cell EngagersEndpoints•Mar 18, 2026•Crossbow, Arkin, MPM BioImpact, LifeLink Ventures and 11 others
•
•
No Barrier Secures $2.7M to Enhance AI Medical Translation and AccessHIT Consultant•Nov 17, 2025•No Barrier AI, Blue Owl, Mobilization For Justice, Arkin and 4 others
•
CyberRidge raises $16M Series A for photonic encryptionCTech•Oct 28, 2025•Arkin, CyberRidge, Redseed, Elron Ventures and 1 other
•
Tech CyberRidge Raises $26M to Protect Subsea Internet DataNewsdirectory3•Oct 28, 2025•Arkin, CyberRidge, Awz Ventures, Redseed and 3 others
